The hexosamine biosynthesis pathway is a targetable liability in lung cancers with concurrent KRAS and LKB1 mutations
Author: J Kim, F Cai, B Ko, C Yang, HM Lee, N Muhammad, et al.
Year Published: 2020
Media Outlet: bioRxiv
Open Access? No
Matrix:
Biological Themes:
Product(s):
Cited in over 3,000 publications, we help scientists and manufacturers gain greater insight into their studies through metabolomics.
Contact Us
Talk with an expert
Request a quote for our services, get more information on sample types and handling procedures, request a letter of support, or submit a question about how metabolomics can advance your research.
Corporate Headquarters
617 Davis Drive, Suite 100
Morrisville, NC 27560
